BioCentury
ARTICLE | Company News

Sciele, sanofi-aventis sales and marketing update

March 3, 2008 8:00 AM UTC

Sciele received exclusive rights to market sanofi-aventis' allergic rhinitis therapeutics Allegra fexofenadine orally disintegrating tablets (ODT) and Allegra oral suspension in the U.S. Under the th...